Status:

COMPLETED

Cohort Study on the Age-related Macular Degeneration: Incidence and Research for Predisposing Factors

Lead Sponsor:

University Hospital, Bordeaux

Conditions:

Elderly French Population

Age-related Macular Degeneration

Eligibility:

All Genders

Phase:

NA

Brief Summary

Age-related Macular Degeneration (AMD) is the most cause of blindness in the industrialised countries. There are few epidemiological studies on the incidence of this disease. Studying the incidence of...

Detailed Description

Age-related Macular Degeneration is the most cause of blindness in the industrialised countries. There are few French epidemiological data on this disease. Worldwide, studies have included a small num...

Eligibility Criteria

Inclusion

  • Subject participating in the study ALIENOR
  • Affiliated to a social security
  • Consent signed by the patient and the investigator

Exclusion

  • \- Health incompatible with one hour and a half ophthalmic examination

Key Trial Info

Start Date :

July 9 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 23 2017

Estimated Enrollment :

516 Patients enrolled

Trial Details

Trial ID

NCT01918553

Start Date

July 9 2015

End Date

February 23 2017

Last Update

April 29 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Unité Médicale Rétine Neuro-Ophtalmologie - Service d'Ophtalmologie - Hopital Pellegrin

Bordeaux, France, 33000

Cohort Study on the Age-related Macular Degeneration: Incidence and Research for Predisposing Factors | DecenTrialz